Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02993991
Title Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

oral squamous cell carcinoma

tongue squamous cell carcinoma

Therapies

Durvalumab + Mocetinostat

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.